Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 272 (RNA5SP272)

Target
RNA5SP272
Molecular classification
Pseudogene, Non-coding RNA, Ribosomal RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 272 (RNA5SP272) is classified as a processed pseudogene—a non-functional copy of the 5S ribosomal RNA gene, located in the human genome[1][2][4][8]. Pseudogenes are DNA sequences resembling functional genes but typically lack the ability to encode a functional product due to mutations or truncations[1][2][4][8]. While some ribosomal RNA pseudogenes can be transcribed and have regulatory roles in gene expression or disease (especially in cancer), there are no reports of functional RNA or biological effects specifically associated with RNA5SP272[6]. It has no known protein products, enzymatic function, or receptor activity, and is not considered a therapeutic target. The main functional 5S rRNA gene encodes a core component of the ribosome, essential for protein synthesis, but this pseudogene does not serve that cellular role[3][5][7]. This entry is likely not clinically or pharmacologically relevant for drug development, biomarker use, or safety assessment. It is possible the entry is included in gene databases for completeness and genomic annotation[1][2][4]. If intended as a therapeutic target or biomarker, this designation would be incorrect due to lack of biological activity and pharmacological relevance.

Other names
RN5S272RNA, 5S ribosomal 272RNA5SP272
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it does not encode a functional product)
04

Disease associations

Other (while some pseudogenes may play regulatory roles, there is no evidence for RNA5SP272 directly involved in disease)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 272 (RNA5SP272).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 272 (RNA5SP272).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call